Paul Tudor Jones Arrowhead Pharmaceuticals, Inc. Transaction History

Tudor Investment Corp Et Al

$26.8 Billion
Q3 2024

A detailed history of Paul Tudor Jones (Tudor Investment Corp Et Al) transactions in Arrowhead Pharmaceuticals, Inc. stock. As of the latest transaction made, Tudor Investment Corp Et Al holds 62,424 shares of ARWR stock, worth $1.31 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

62,424

Holding current value

$1.31 Million

% of portfolio

0.0%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$19.36 - $29.54 $1.21 Million - $1.84 Million	62,424 New	62,424 $1.21 Million
Q1 2024 May 15, 2024	BUY	$27.21 - $39.48 $1.6 Million - $2.32 Million	58,729 Added 553.99%	69,330 $1.98 Million
Q4 2023 Feb 14, 2024	BUY	$21.2 - $31.03 $224,741 - $328,949	10,601 New	10,601 $324,000
Q1 2023 May 15, 2023	BUY	$23.68 - $38.51 $1.6 Million - $2.6 Million	67,587 New	67,587 $1.72 Million
Q3 2022 Nov 14, 2022	BUY	$29.63 - $48.31 $764,957 - $1.25 Million	25,817 Added 122.6%	46,875 $1.55 Million
Q2 2022 Aug 15, 2022	SELL	$27.79 - $50.61 $560,968 - $1.02 Million	-20,186 Reduced 48.94%	21,058 $741,000
Q1 2022 May 16, 2022	BUY	$39.62 - $69.97 $1.63 Million - $2.89 Million	41,244 New	41,244 $1.9 Million
Q3 2021 Nov 15, 2021	SELL	$58.38 - $84.96 $358,453 - $521,654	-6,140 Closed	0 $0
Q2 2021 Aug 16, 2021	SELL	$62.15 - $90.32 $1.77 Million - $2.58 Million	-28,558 Reduced 82.3%	6,140 $509,000
Q1 2021 May 17, 2021	BUY	$61.35 - $90.47 $2.13 Million - $3.14 Million	34,698 New	34,698 $2.3 Million
Q2 2020 Aug 14, 2020	SELL	$26.12 - $43.27 $228,341 - $378,266	-8,742 Closed	0 $0
Q1 2020 May 15, 2020	BUY	$20.56 - $63.12 $94,370 - $289,720	4,590 Added 110.55%	8,742 $252,000
Q4 2019 Feb 14, 2020	BUY	$28.14 - $73.01 $116,837 - $303,137	4,152 New	4,152 $263,000
Q1 2018 May 15, 2018	SELL	$3.72 - $7.64 $182,536 - $374,887	-49,069 Closed	0 $0
Q4 2017 Feb 14, 2018	BUY	$3.14 - $4.5 $95,471 - $136,822	30,405 Added 162.91%	49,069 $181,000
Q3 2017 Nov 14, 2017	BUY	$1.69 - $4.33 $31,542 - $80,815	18,664	18,664 $81,000

Others Institutions Holding ARWR

# of Institutions

295

Shares Held

91.1M

Call Options Held

155K

Put Options Held

426K

View Full List

About ARROWHEAD PHARMACEUTICALS, INC.

Ticker ARWR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 105,849,000
Market Cap $2.23B
Description
Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. The company's products in pipeline includes ARO-AAT, a RNA interference (RNAi) therapeutic candidate that is in Phase II clinical trial for the treatment of liver diseases associated with alpha-1 antitrypsin deficiency; ARO-APOC3, w...

More about ARWR

Track Paul Tudor Jones's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Tudor Investment Corp Et Al, based on Form 13F filings with the SEC.

News

Stay updated on Tudor Investment Corp Et Al and Paul Tudor Jones with notifications on news.

Account